Jared Gollob, Chief Medical Officer at Kymera Therapeutics, Inc. (KYMR), sold 74,128 shares at $52.63 ($3.8M) on 2021-02-22, disclosed to the SEC on 2021-02-24.
Open-market sale of $3.8M KYMR by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.63 | 9,104 | $479K | 12.8% |
| 2 | $52.63 | 9,104 | $479K | 12.8% |
| 3 | $49.65 | 19,285 | $958K | 25.5% |
| 4 | $49.65 | 19,285 | $958K | 25.5% |
| 5 | $50.91 | 8,675 | $442K | 11.8% |
| 6 | $50.91 | 8,675 |
| $442K |
| 11.8% |
| Total | $50.68 avg | 74,128 | $3.8M | 100% |
| Filing → |
| KYMR | SELL | 2025-10-15 | $7.3M | — | Filing → |
| KYMR | SELL | 2025-10-14 | $187K | — | Filing → |
| KYMR | SELL | 2025-03-03 | $317K | — | Filing → |